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ABSTRACT
Introduction: Historically, Kenya has used various
distribution models for long-lasting insecticide-treated
bed nets (LLINs) with variable results in population
coverage. The models presently vary widely in scale,
target population and strategy. There is limited
information to determine the best combination of
distribution models, which will lead to sustained high
coverage and are operationally efficient and cost-
effective. Standardised cost information is needed in
combination with programme effectiveness estimates
to judge the efficiency of LLIN distribution models and
options for improvement in implementing malaria
control programmes. The study aims to address the
information gap, estimating distribution cost and the
effectiveness of different LLIN distribution models, and
comparing them in an economic evaluation.
Methods and analysis: Evaluation of cost and
coverage will be determined for 5 different distribution
models in Busia County, an area of perennial malaria
transmission in western Kenya. Cost data will be
collected retrospectively from health facilities, the
Ministry of Health, donors and distributors.
Programme-effectiveness data, defined as the number
of people with access to an LLIN per 1000 population,
will be collected through triangulation of data from a
nationally representative, cross-sectional malaria
survey, a cross-sectional survey administered to a
subsample of beneficiaries in Busia County and LLIN
distributors’ records. Descriptive statistics and
regression analysis will be used for the evaluation.
A cost-effectiveness analysis will be performed from a
health-systems perspective, and cost-effectiveness
ratios will be calculated using bootstrapping
techniques.
Ethics and dissemination: The study has been
evaluated and approved by Kenya Medical Research
Institute, Scientific and Ethical Review Unit (SERU
number 2997). All participants will provide written
informed consent. The findings of this economic
evaluation will be disseminated through peer-reviewed
publications.
BACKGROUND
In Kenya, ﬁve channels of distributing long-
lasting insecticide-treated bed nets (LLINs)
have been used historically in the implemen-
tation of malaria control programmes with
variable results in population coverage.1–6 In
2004, when LLINs were distributed through
the commercial retail sector and heavily
subsidised social marketing schemes in rural
shops and public health facilities, LLIN
coverage was estimated at 7.1%.5 6 By 2005,
coverage with LLINs increased to 23.5% with
the provision of free LLINs in antenatal care
and child health clinics in public health facil-
ities.7 In 2011, LLIN coverage dramatically
increased to 67% after free distribution of
LLINs in a Ministry of Health (MoH) mass
distribution campaign with the goal of uni-
versal coverage, deﬁned as one LLIN per two
people in each household.1–4 In addition,
since 2001, heavily subsidised LLINs have
been distributed through social marketing
outlets in rural areas (ie, ∼600 000–800 000
nets annually).1 3 In 2012, the National Malaria
Strengths and limitations of this study
▪ It is the first study to look at the cost-effective-
ness of parallel net distribution channels and
coverage results that can be expected from each
channel based on financial inputs.
▪ Provide evidence on the costs and resources
required to deliver LLINs using current distribu-
tion channels and to assist in determining the
efficient allocation of resources.
▪ The study is localised in one county of western
Kenya; therefore, the results might not be repre-
sentative or generalizable to all of Kenya or other
countries.
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Control Programme (NMCP)/MoH began a concerted
effort to scale up malaria community case management.
Using community health volunteers to distribute nets, a
continuous LLIN distribution pilot project was imple-
mented in 2014–2015 in Samia, an administrative loca-
tion in Funyula division of Busia County in western
Kenya.
Post-campaign surveys after the rolling 2011–2012 uni-
versal coverage mass distribution demonstrated low
LLIN usage among all age groups.8 For children
<5 years of age, usage ranged from 28% to 59% across
the different malaria epidemiological zones and 31% to
50% in the general population across zones.5 9 10 The
proportion of persons using LLINs did not increase sig-
niﬁcantly after the 2011–2012 mass campaign compared
with the 2010 Kenya Malaria Indicator Survey (KMIS),
which showed that the proportions of children under
5 years of age and general population who slept under
an LLIN the previous night was 42% and 39%,
respectively.5 9 10
By mid-2014, only 34% of households nationally met
the universal coverage indicator of one LLIN per two
people.11 Access to nets, deﬁned by attaining universal
coverage at the household level, is directly associated
with use of nets by both children under 5 years of age
and all household members. In households that met
universal coverage (ie, having at least one LLIN for
every two people), 87% of children under 5 years of age
slept under a net the previous night compared with 49%
in households without universal coverage.7 Thus, a
major part of the solution to increasing net use in Kenya
is to increase the number of nets within a household to
ensure universal coverage. Despite multiple functional
distribution channels and massive investments, LLIN
coverage still remains well below the Kenya National
Malaria Strategy (NMS) 2009─2017 and WHO goals of
having at least 80% of people living in malaria-risk areas
using LLINs.2 5 9
Studies from various parts of Africa indicate that the
use of LLINs has a beneﬁcial effect on malaria transmis-
sion, severe malaria and mortality.12 13 Similarly, there
are numerous studies demonstrating the cost-
effectiveness of LLINs in different parts of the world
and in various contexts.14–18 However, information is
limited on the actual costs of parallel distribution chan-
nels in the same context and coverage results that can
realistically be achieved from each channel based on
ﬁnancial inputs.19 In 2013, Kenya devolved responsibility
for health service delivery from the central government
to 47 county governments as mandated in the 2010
Constitution of Kenya. This major restructuring poten-
tially creates challenges due to inconsistencies in prac-
tice, duplicate structures and may hamper malaria
control.
In this new and evolving health services delivery
context in Kenya, the NMCP/MoH, counties, donors
and stakeholders require evidence-based cost-
effectiveness data on LLIN distribution channels to
make informed, rational decisions for programme
implementation and targets. This study is intended to
help provide the evidence required for decision-making.
The goals of this economic evaluation are therefore to
determine the actual cost of delivering a net to the end
user in each channel and the coverage levels that can be
achieved given a ﬁnancial input. The economic evalu-
ation results will help inform policy and programme
implementation by establishing the costs and outcomes
for each LLIN distribution channel in Kenya.
Objectives
The main objective of the economic evaluation is to
assess the allocative efﬁciency of a limited budget to
support implementation of LLINs as a prevention strat-
egy and determine the most cost-effective mix of LLIN
distribution channels that would maximise coverage for
beneﬁciaries.
Specific objectives
Determine and compare the unit cost associated with
distributing an LLIN to a beneﬁciary through the follow-
ing distribution channels:
A. Universal coverage mass distribution campaigns;
B. Routine distribution through antenatal and child
health clinics;
C. Continuous community distribution by community
health volunteers;
D. Social marketing by community-based organisations
through rural outlets;
E. Commercial retail outlets.
Determine and compare the proportion of coverage
deﬁned as the following:
A. Universal coverage (ie, one LLIN per two people per
household);
B. At least one LLIN per household.
The principal health economic research question is:
do the current LLIN distribution channels represent an
efﬁcient allocation of scarce resources?
Therefore, the speciﬁc health economics research ques-
tions are as follows:
A. What is the impact of the current LLIN distribution
channels on health system costs?
B. What are the costs and outcomes of the ﬁve different
LLIN distribution channels?




The study is a retrospective economic evaluation from
the provider’s perspective involving ﬁve arms to
compare the costs and effectiveness of the LLIN distri-
bution channels in Busia County, western Kenya. The
arms of the study are shown in ﬁgure 1.
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Description of LLIN distribution channels (comparators)
The ﬁve different LLIN distribution channels that will
be evaluated are brieﬂy described here and illustrated in
ﬁgure 1.
1. Universal coverage mass distribution campaigns
which entail the distribution of LLINs to all house-
holds in endemic and epidemic-prone areas (ie, 23
counties) every 3 years. The campaign is planned
and implemented by the NMCP/MoH with ﬁnancial
support from donors. The LLINs are procured by the
NMCP/MoH and donors and distributed to health
facilities in the 23 counties as part of the procure-
ment contract. Prior to distribution, a household
registration is undertaken whereby small teams of
local MoH staff and community leaders register all
households and the number of persons per house-
hold in a given geopolitical location or catchment
area. The LLINs are distributed to health facilities
and central storage points in each county based on
the household registration. The head of the house-
hold or designated person comes to the designated
health facility during the campaign time frame,
which is generally 3–5 days, to collect the number of
LLINs based on the number of persons registered in
their household. One LLIN per two persons per
household is provided free of charge to beneﬁciaries.
In Kenya, there is no household distribution of
LLINs during the campaign or after. Registered
persons who do not come to the health facilities to
collect LLINs do not receive nets. Households
receive communications for both the household
registration and campaign distribution dates through
community meetings, local radio announcements,
health facilities and other communication channels.
The local MoH and county government leadership
comprise the majority of staff for mass LLIN distribu-
tion campaigns. In the rolling 2014–2015 universal
coverage mass distribution campaign, ∼12.3 million
LLINs were distributed in 23 counties.5
2. Routine distribution of one free LLIN to every preg-
nant woman at the ﬁrst antenatal clinic visit and to
every child <1-year of age at the ﬁrst immunisation
visit in public and non-for-proﬁt health facilities in
endemic, epidemic-prone and seasonal transmission
areas (ie, 36 counties). The distribution of LLINs via
antenatal care and child health clinics is implemen-
ted by a non-governmental organisation (NGO) in
coordination with the NMCP/MoH and with ﬁnan-
cial support from donors. All routine LLINs are pro-
cured through two NGO partners. All routine LLINs
are transported, stored in regional warehouses and
distributed to health facilities by the second NGO
partner. The second NGO partner manages all
aspects of the supply chain for LLINs in accordance
with national policy and in coordination with the
NMCP/MoH. In 2015, ∼3 million LLINs will be dis-
tributed to meet NMCP/MoH targets for routine
antenatal care and child health clinic distribution.
3. Pilot continuous LLIN distribution project using
community health volunteers to distribute vouchers
for nets to community members in a portion of one
county. The community health volunteers conﬁrm
the need for new LLINs at the household level,
either because the household does not have enough
LLINs for universal coverage or to replace worn, non-
protective nets. The voucher is taken by the commu-
nity member to a designated community health facil-
ity and redeemed for free LLINs. The pilot project
was implemented in three sub-counties in Busia
County, western Kenya. The pilot was implemented
Figure 1 Concept map of economic evaluation of long-lasting insecticide-treated bed nets distribution channels in Busia
County, Kenya.
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by an NGO partner in coordination with the NMCP/
MoH and with ﬁnancial support from donors. All
LLINs were procured, transported, stored and distrib-
uted to health facilities by the NGO partner. The
NGO partner managed all aspects of the voucher
process and LLIN supply chain in coordination with
the NMCP/MoH. The community health volunteers
are each assigned ∼50 households in a village and
are linked to health dispensaries or health centres
for reporting purposes, commodity supply (eg,
malaria rapid diagnostic tests and medications for
case management) and supervision by the commu-
nity health extension worker. The community health
volunteers do not get a formal salary but receive a
modest stipend from the county government or NGO
partners.3 Approximately 100 000 nets were intended
for the continuous community distribution pilot
project from October 2014 to March 2015.
4. Social marketing of heavily subsidised LLINs in rural
shops and by community-based organisations in
endemic, epidemic-prone and seasonal transmission
areas, including Busia County. The distribution of
socially marketed LLINs is a partnership between a
primary NGO partner, multiple community-based
organisations, rural outlets and the NMCP/MoH and
with ﬁnancial support from donors. All socially mar-
keted LLINs are procured, transported, stored and
distributed to the sellers by the primary NGO
partner. The NGO partner manages all aspects of the
supply chain for LLINs in coordination with the
NMCP/MOH. The rural shops and community-based
organisations use communications mechanisms such
as community gatherings, local radio and TV shows
and advertisements, competitions, drama and theatre
to attract customers. In 2015, the target price for a
socially marketed LLIN was ∼US$1.50 to the cus-
tomer. Approximately 600 000–800 000 LLINs are
sold via social marketing channels annually.
5. Commercial, for-proﬁt-sector retailers stock and sell
LLINs at market prices throughout Kenya. Prices vary
widely based on geographic location, target market,
manufacturer, brand, size, material and other factors.
Cost data will be collected retrospectively from a provi-
der’s perspective from health facilities, NMCP/MoH,
NGO partners, donors, stakeholders, distributors and
the Kenya Medical Supply Agency (KEMSA). KEMSA is
the central medical store and provides supply chain
management of malaria commodities from the national
to facility levels. Data on outcomes will be triangulated
from a nationally representative cross-sectional survey of
over 6300 households, a cross-sectional survey adminis-
tered to a subsample of beneﬁciaries in Busia County,
and distributors’ records. The evaluation will involve
comparing the costs of distribution and outcomes for
each distribution channel. For cost estimates, we will use
a bottom-up approach, combining activity-based costing
(ABC), ingredient approach and budget expenditure
data.20 21 The bottom-up approach is an established
micro-costing technique that has been successfully
applied to diverse settings in corporate and healthcare
sectors.20–24 In contrast to traditional costing systems, in
which direct, indirect and overhead costs are aggregated
and assigned proportionally based on unit volume pro-
duced or services delivered, micro-costing assigns costs
more accurately by delineating speciﬁc services or pro-
cesses responsible for actual resource consumption.
Resources will be organised into cost categories as sum-
marised in table 1. Cost drivers from each cost category
will be quantiﬁed and unit cost per net distributed will
be calculated.
Cost data will be obtained from ﬁnancial reports and
budgets of NGO partners, NMCP/MoH, KEMSA and
Table 1 Description of key categories of costs and
sources




MOH, sub-county health offices,
partner records and staff
interviews
Transport
Vehicles MOH, sub-county health offices,








Personal protective MOH, sub-county health offices,






LLINs MOH, sub-county health offices,








MOH, county health offices,
implementing partners records,










LLINs, long-lasting insecticide-treated bed nets; MOH, Ministry of
Health.
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Busia County Directorate of Health, community-based
organisations, Ministry of Finance/National Treasury
and other available sources. To ease understanding and
facilitate comparisons, costs in Kenya shillings will be
converted into US dollars depending on the currency of
the original expenditure and the average Kenya Central
Bank exchange rate for the period of the expenditure.
Sample size calculations
For outcome data, a cross-sectional survey will be con-
ducted in randomly selected households in Busia
County to collect data on coverage and source of nets. A
list of households will be obtained from the community
unit registers. The sample size was calculated assuming a
universal coverage of 40% (deﬁned as one LLIN per two
persons per household). The least effect size in LLIN
coverage levels expected from the distribution channels
is 15%. This will result in a minimum sample size of 456
households to be surveyed assuming a 5% margin of
error and 80% power to detect differences in coverall
levels. An additional 30% to account for refusals and
absentees during the survey will be added to obtain a
target sample size of 592 households.
Interviewers will explain to all participants that involve-
ment in the study is voluntary and that they have the
right to withdraw at any point in time and ask any ques-
tions. Information about the study will be read to all par-
ticipants and provided in a hard copy. All consenting
participants will be asked to sign two standard consent
forms (ie, one for the interviewee and one retained by
the interviewer).
Effectiveness measures
The main effectiveness measure is the percentage of
persons using an LLIN for malaria prevention in at-risk
areas; the NMCP/MoH and WHO target for this indica-
tor is at least 80% of the population.5 Two additional
effectiveness measures will be based on the WHO and
the Roll Back Malaria Monitoring and Evaluation
Reference Group (RBM MERG) indicators used for
monitoring achievement of universal coverage: percent-
age of households with universal coverage with LLINs
(ie, one LLIN per two persons per household) and per-
centage of households with at least one LLIN.5
The main health economics-related outcomes are the
total and unit cost of distributing an LLIN through each
of the ﬁve current distribution channels. Additional
health economics outcomes are the mean and median
cost by distribution channel categorised by quartiles and
household outcome, the total and mean cost by distribu-
tion channel and by cost category and the incremental
cost of the distribution channel compared with other
channels. Savings will be recorded as negative incremen-
tal costs.
Economic evaluation
The cost and effectiveness of the outcomes of the ﬁve
distribution channels will be compared with each other
and analysed using cost-effectiveness methods.15–19 To
analyse the effectiveness of the distribution channel with
regard to the cost and outcome measures, descriptive
statistics and a generalised linear regression model will
be used because cost data are usually not normally dis-
tributed.15–18 The analysis will include comparison of
the different distribution channels as well as a multilevel
analysis focusing on cost categories.
Cost-effectiveness ratios will be calculated based on
the primary outcome measure in relation to a range of
health economics outcomes (eg, total, mean, median
and incremental costs) for each LLIN distribution
channel. Financial costs will be adjusted to obtain eco-
nomic costs and assign costs to donated items as well as
time of volunteers included in some of the distribution
channels. The LLIN distribution channels are generally
expected to perform for more than 1-year and the
capital items purchased to deliver the LLINs have a life
expectancy in excess of 1-year. Similarly, LLINs are
intended to last for 3 years in ﬁeld conditions.19 25 26
Therefore, capital costs will be expressed as an annual
equivalent. Capital inputs that will be annualised are
LLINs, vehicles and equipment using 3.5% as a dis-
counting rate.15–19
Cost-effectiveness will be calculated for each compari-
son and will be expressed as incremental cost-
effectiveness ratios (ICERs). Mass campaigns are by far
the largest channel by volume and assumed to be the
least expensive and most efﬁcient channel for distribut-
ing LLINs in Kenya; therefore, the campaign distribu-
tion channel will be used as a baseline for the
comparative analysis. Owing to time and resource con-
straints, the economic evaluation (ie, cost-effectiveness
component) will be performed from a health systems
perspective (ie, distributors and donors). ICERs will be
estimated using bootstrapping techniques and graphic-
ally presented on cost-effectiveness planes.21–24 For com-
parisons and ease of understanding, costs will generally
be quoted in US dollars.
Cost estimates inevitably involve assumptions and
uncertainty. Therefore, we will carefully identify critical
assumptions and areas of uncertainty and re-estimate
the results using different assumptions to test the sensi-
tivity of the results and conclusions due to such change.
We will perform both one-way and multi-way sensitivity
analysis in order to assess the robustness of the results
and examine the effect of common assumptions and
uncertain variables on the evaluation ﬁndings.27 28 An a
priori analysis plan was developed and agreed on prior
to the initiation of data collection and analysis.
Discussion and conclusion
Although there is robust literature around LLINs as the
main malaria prevention and control strategy, there are
very limited data on the cost-effectiveness of LLIN distri-
bution channels in ﬁeld settings. Therefore, NMCPs, sta-
keholders and donors have limited information on
which to base policy and plan programmatic
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implementation to meet national and international
LLIN coverage target indicators. This economic evalu-
ation is intended to provide the NMCP/MoH, partners,
stakeholders and donors with evidence on the costs and
resources required to deliver LLINs using current distri-
bution channels and to assist in determining the efﬁ-
cient allocation of resources to meet target outcome
measures.
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